Login / Signup

Diet of Broilers with Essential Oil from Citrus sinensis and Xylopia aromatica Fruits.

Marcela ChristofoliWeslane Justina da SilvaNathan Ferreira da SilvaNadielli Pereira BonifácioChristiane Silva SouzaFabiano Guimarães SilvaPaulo Sérgio PereiraCibele Silva Minafra
Published in: Animals : an open access journal from MDPI (2023)
This study aimed to evaluate the effects of essential oils from the fruits of Citrus sinensis and Xylopia aromatica , included in broiler feed, on blood parameters, the biometrics of digestive organs, bone analyses, and the biochemical profiles of the viscera, as well as the histomorphometry of the small intestine. In this study, 180 one-day-old male chicks of the Cobb 500 strain were fed a corn and soybean meal over three treatments and six replications, and the experimental design was completely randomized. The data were subjected to an analysis of variance and a Tukey test at a 5% significance level. The effect of the experimental diets on performance, blood parameters, biometrics of the digestive organs, bone analysis, and biochemical profiles of the viscera, as well as the histomorphometry of the small intestine, were evaluated. The compounds identified in the essential oil of X. aromatica were sylvestrene, α-pinene, and β-pinene, while in C. sinensis they were limonene and myrcene. The essential oils of C. sinensis and X. aromatica had no significant effect on performance at 14 days. The effects of the presence of the essential oils of C. sinensis and X. aromatica on the response were beneficial: there were reductions in liver lipids, cholesterol, and triglycerides, and in the depths of the crypts in the jejunum of chickens. So, the essential oils from the fruits of C. sinensis and X. aromatica can be used in broiler chickens to improve the lipid profiles of birds without affecting their performance.
Keyphrases
  • essential oil
  • heat stress
  • weight loss
  • bone mineral density
  • physical activity
  • open label
  • randomized controlled trial
  • electronic health record
  • clinical trial
  • fatty acid
  • body composition
  • big data
  • phase ii